- New

Rubelsus containing "semaglutide" what is used to manage type 2 diabetes. It works by stimulating insulin release and reducing appetite. Support both: glucose control and potential weight loss. Taken as an oral tablets, it is typically used alongside diet and excercise.
(edit with the Customer Reassurance module)
(edit with the Customer Reassurance module)
(edit with the Customer Reassurance module)
RYBELSUS semaglutide tablets
INTRODUCING RYBELSUS®, THE FIRST AND ONLY ORAL GLP-1 RA*
Dear healthcare professional,
Novo Nordisk is pleased to announce the launch of RYBELSUS® in Canada! RYBELSUS® (semaglutide tablets) is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus:1
- as monotherapy when metformin is considered inappropriate due to intolerance or contraindications
- in combination with other medicinal products for the treatment of diabetes (see clinical trials in the Product Monograph for patient populations and drug combinations tested